Apr 22, 2024
Neola Medical’s lung monitoring is user-friendly and safe. These are the results of the usability study cunducted during the spring. “Successful study results are of great importance as we will use them as part of our upcoming FDA application for market approval in...
Apr 18, 2024
Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company’s medical device for continuous lung...
Apr 11, 2024
️Press communication Lund, Sweden, April 10, 2024 Read the entire press release here: Press release – KALLELSE TILL ÅRSSTÄMMA I NEOLA MEDICAL AB For further information, contact: Hanna Sjöström, CEO Neola Medical, phone: +46 (0)760-10 71 16, e-mail:...
Apr 9, 2024
Press communication Lund, Sweden, April 9, 2024 This is a translation of the Swedish press release published 2024-04-09 Neola Medical AB (publ) announces that the Annual report of 2023 now is available at the company’s website, and attached to the press release....
Mar 28, 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical’s product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising...
Mar 22, 2024
“With great potential for the youngest” – reads the title as CEO Hanna Sjöström joins venture capitalist Jan Dahlqvist in this week’s Lejonkulan, the new podcast of Rapidus, which for the first time hosts a listed company. Listen to the entire...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
